Jeongmin Hong, PhD
Postdoctoral Associate
Boston University Chobanian & Avedisian School of Medicine
Arthritis & Autoimmune Diseases Research Center

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Shiba-Ishii A, Isagawa T, Shiozawa T, Mato N, Nakagawa T, Takada Y, Hirai K, Hong J, Saitoh A, Takeda N, Niki T, Murakami Y, Matsubara D. Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC. Biochim Biophys Acta Mol Basis Dis. 2024 Aug; 1870(6):167249. PMID: 38768929
  2. Hong J, Shiba-Ishii A, Kim Y, Noguchi M, Sakamoto N. Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma. Cancer Sci. 2021 Dec; 112(12):5114-5126. PMID: 34628698; PMCID: PMC8645747; DOI: 10.1111/cas.15160;
  3. Hong J, Kim Y, Kano J, Dai T, Noguchi M. miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Journal of Thoracic Oncology. 2021. View Publication
  4. Hong J, Kim Y, Shiba-Ishii A, Noguchi M. P1.03-18 OCIAD2 Impairs Mitochondria-Mediated Apoptosis Through Substantial Alteration of Crista Structure in Lung Adenocarcinoma. Journal of Thoracic Oncology. 2019. View Publication
  5. Husni RE, Shiba-Ishii A, Nakagawa T, Dai T, Kim Y, Hong J, Sakashita S, Sakamoto N, Sato Y, Noguchi M. DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma. Oncotarget. 2019 Feb 26; 10(17):1625-1636. PMID: 30899432; PMCID: PMC6422190; DOI: 10.18632/oncotarget.26676;
  6. Shiba-Ishii A, Hong J, Hirokawa T, Kim Y, Nakagawa T, Sakashita S, Sakamoto N, Kozuma Y, Sato Y, Noguchi M. Stratifin Inhibits SCFFBW7 Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis. Clin Cancer Res. 2019 May 01; 25(9):2809-2820. PMID: 30728155; DOI: 10.1158/1078-0432.CCR-18-3631;
  7. Shiba A, Hong J, Hirokawa T, Kim Y, Noguchi M. P1. 03-20 The Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination. Journal of Thoracic Oncology. 2018. View Publication
  8. Sato T, Shiba-Ishii A, Kim Y, Dai T, Husni RE, Hong J, Kano J, Sakashita S, Iijima T, Noguchi M. miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Cancer Sci. 2017 Mar; 108(3):536-542. PMID: 28012229; PMCID: PMC5378261; DOI: 10.1111/cas.13148;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 8 publications over 5 distinct years, with a maximum of 3 publications in 2019


Contact for Mentoring:

Hong's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department